6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03552068 (ClinicalTrials.gov)	May 15, 2019	17/5/2018	Study of Clonidine Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease:	Study of ClonidineEfficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease: A ...	Parkinson's Disease;Mpulse Control Disorders	Drug: placebo;Drug: Clonidine	Hospices Civils de Lyon	NULL	Completed	30 Years	80 Years	All	38	Phase 2	France
2	NCT01370811 (ClinicalTrials.gov)	August 2011	8/6/2011	A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson' ...	A Phase II, Double-blind, Randomized, Placebo-controlled 4-way Crossover Study to Evaluate the Relat ...	Sialorrhoea	Drug: OC oral solution treatment A;Drug: OC oral solution treatment B;Drug: OC oral solution treatme ...	Orient Pharma Co., Ltd.	NULL	Completed	40 Years	80 Years	Both	24	Phase 2	United States
3	EUCTR2007-004654-81-GB (EUCTR)	20/12/2007	16/10/2007	A phase IIa study to evaluate the relative efficacy and safety/tolerability of a single agent vs. a ...	A phase IIa study to evaluate the relative efficacy and safety/tolerability of a single agent vs. a ...	Sialorrhoea associated with Parkinson's Disease MedDRA version: 9.1;Level: LLT;Classification code 1 ...	Trade Name: Catapres ampoules INN or Proposed INN: Clonidine hydrochloride Trade Name: Ditropan elixir I ...	Summit (Cambridge) Ltd.	NULL	Not Recruiting			Female: yes Male: yes		Phase 2	United Kingdom

First Previous1Next Last